CL2023000451A1 - Vacunas vivas liofilizadas de bordetella - Google Patents
Vacunas vivas liofilizadas de bordetellaInfo
- Publication number
- CL2023000451A1 CL2023000451A1 CL2023000451A CL2023000451A CL2023000451A1 CL 2023000451 A1 CL2023000451 A1 CL 2023000451A1 CL 2023000451 A CL2023000451 A CL 2023000451A CL 2023000451 A CL2023000451 A CL 2023000451A CL 2023000451 A1 CL2023000451 A1 CL 2023000451A1
- Authority
- CL
- Chile
- Prior art keywords
- bordetella bacteria
- freeze
- bordetella
- bacteria
- lyophilization buffer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/04—Preserving or maintaining viable microorganisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063066020P | 2020-08-14 | 2020-08-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2023000451A1 true CL2023000451A1 (es) | 2023-10-20 |
Family
ID=80247370
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2023000451A CL2023000451A1 (es) | 2020-08-14 | 2023-02-14 | Vacunas vivas liofilizadas de bordetella |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230173053A1 (enExample) |
| EP (1) | EP4196155A4 (enExample) |
| JP (1) | JP7809362B2 (enExample) |
| KR (1) | KR20230051186A (enExample) |
| CN (1) | CN116322756A (enExample) |
| AU (1) | AU2021325149A1 (enExample) |
| BR (1) | BR112023002549A2 (enExample) |
| CA (1) | CA3187934A1 (enExample) |
| CL (1) | CL2023000451A1 (enExample) |
| CO (1) | CO2023002823A2 (enExample) |
| MX (1) | MX2023001905A (enExample) |
| WO (1) | WO2022036298A1 (enExample) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2215033C2 (ru) * | 2001-06-27 | 2003-10-27 | Научно-исследовательский институт микробиологии МО РФ | Способ получения концентрата микробных клеток в производстве чумных вакцин |
| EP1708747A2 (en) * | 2004-01-15 | 2006-10-11 | Intervet International BV | Non-animal origin stabilizers and processes for producing the same |
| US9119804B2 (en) | 2006-03-10 | 2015-09-01 | Institut Pasteur De Lille | Live attenuated bordetella strains as a single dose vaccine against whooping cough |
| EP2722338A1 (en) | 2012-10-17 | 2014-04-23 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Novel recombinant Bordetella strains |
| AR097762A1 (es) * | 2013-09-27 | 2016-04-13 | Intervet Int Bv | Formulaciones secas de vacunas que son estables a temperatura ambiente |
| EP4541809A3 (en) | 2016-03-29 | 2025-06-25 | Institut Pasteur de Lille | Mutant bordetella strains and methods of use |
| RU2709657C2 (ru) * | 2017-08-07 | 2019-12-19 | федеральное государственное бюджетное учреждение "Национальный исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи" Министерства здравоохранения Российской Федерации (ФГБУ "НИЦЭМ им. Н.Ф. Гамалеи" Минздрава России) | Способ лиофильного высушивания аттенуированных бактерий B. pertussis, аттенуированная бактерия B. pertussis, штамм аттенуированных бактерий B. Pertussis, вакцина, лиофилизированный вакцинный препарат |
| WO2020049133A1 (en) | 2018-09-05 | 2020-03-12 | National University Of Singapore | Adenylate cyclase catalytic domain deficient bordetella strains |
-
2021
- 2021-08-15 AU AU2021325149A patent/AU2021325149A1/en active Pending
- 2021-08-15 BR BR112023002549A patent/BR112023002549A2/pt unknown
- 2021-08-15 EP EP21856843.4A patent/EP4196155A4/en active Pending
- 2021-08-15 CA CA3187934A patent/CA3187934A1/en active Pending
- 2021-08-15 MX MX2023001905A patent/MX2023001905A/es unknown
- 2021-08-15 KR KR1020237004612A patent/KR20230051186A/ko active Pending
- 2021-08-15 JP JP2023510359A patent/JP7809362B2/ja active Active
- 2021-08-15 WO PCT/US2021/046055 patent/WO2022036298A1/en not_active Ceased
- 2021-08-15 CN CN202180055776.1A patent/CN116322756A/zh active Pending
-
2023
- 2023-01-25 US US18/159,550 patent/US20230173053A1/en active Pending
- 2023-02-14 CL CL2023000451A patent/CL2023000451A1/es unknown
- 2023-03-07 CO CONC2023/0002823A patent/CO2023002823A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20230173053A1 (en) | 2023-06-08 |
| CA3187934A1 (en) | 2022-02-17 |
| JP7809362B2 (ja) | 2026-02-02 |
| WO2022036298A1 (en) | 2022-02-17 |
| JP2023540453A (ja) | 2023-09-25 |
| AU2021325149A1 (en) | 2023-03-02 |
| CN116322756A (zh) | 2023-06-23 |
| EP4196155A1 (en) | 2023-06-21 |
| KR20230051186A (ko) | 2023-04-17 |
| MX2023001905A (es) | 2023-03-13 |
| EP4196155A4 (en) | 2025-03-19 |
| CO2023002823A2 (es) | 2023-03-27 |
| BR112023002549A2 (pt) | 2023-03-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6896802B2 (ja) | 室温安定であるワクチンの乾燥製剤 | |
| MX2024005641A (es) | Composiciones y metodos para la liofilizacion de bacterias o cepas de listeria. | |
| PE20140871A1 (es) | COMPOSICIONES Y METODOS DE VACUNA DEL VIRUS TIPO 1b DE DIARREA VIRAL BOVINA | |
| CL2023000451A1 (es) | Vacunas vivas liofilizadas de bordetella | |
| CN104212733A (zh) | 一种光合细菌冻干保护剂 | |
| CN103316355A (zh) | 一种伪狂犬病活疫苗及制备方法 | |
| ES2269672T3 (es) | Vacuna contra mycoplasma inactivado por saponina. | |
| CN102626520A (zh) | 一种水貂犬瘟热活疫苗耐热冻干保护剂及制备方法 | |
| CN103981151B (zh) | 一种伪狂犬灭活疫苗及其制备方法 | |
| AR132234A1 (es) | Método para la fabricación de vacunas virales y composiciones de las mismas | |
| ES2362035B2 (es) | Cepa bacteriana cect7624, usos y producto xeroprotector producido por la misma. | |
| CN102380093A (zh) | 一种利用传代成纤维细胞生产鸡新城疫活疫苗的方法 | |
| Wei et al. | First report of Achromobacter xylosoxidans causing stem soft rot on Amorphophallus konjac in China | |
| CN106085968B (zh) | 一种水貂伪狂犬灭活疫苗及其制备方法和用途 | |
| Emmons et al. | Isolation of Histoplasma capsulatum from fresh and deep-frozen peribronchial lymph nodes of dogs by mouse inoculation | |
| CN103301453A (zh) | 一种猪繁殖与呼吸综合征冻干疫苗及其制备方法 | |
| CN1059701C (zh) | 马传染性贫血病驴白细胞弱毒株及其培育方法 | |
| MD1379Z (ro) | Procedeu de conservare a tulpinii de levuri Saccharomyces cerevisiae CNMN-Y-20 | |
| Zakutskii et al. | Immunobiological features of an attenuated African swine fever virus strain FK-135 grown in a porcine bone marrow cell suspension | |
| Shahzad | IMPACT OF GLYCEROL AND DIMETHYL SULFOXIDE ON THE PERSISTENCE OF PASTEURELLA MULTOCIDA DURING ITS PRESEVATION AT DIFFERENT TEMPERATURES | |
| RU2015131897A (ru) | Способ получения стерильной лиофилизированной добавки из личинок и куколок трутней | |
| RU2421512C1 (ru) | Питательная среда для культивирования энтомопатогенных грибов | |
| CN121868471A (zh) | 鸡传染性喉气管炎重组鸡痘病毒基因工程疫苗的冻干保护剂及其制备方法与应用 | |
| MD1380Z (ro) | Procedeu de conservare a tulpinii de levuri Saccharomyces cerevisiae CNMN-Y-20 | |
| Petney et al. | Argas polonicus Siuda, Hoogstraal, Clifford and Wassef, 1979 (Fig. 6) |